Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Free Cash Flow (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Free Cash Flow for 16 consecutive years, with $16.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 10.67% year-over-year to $16.8 million, compared with a TTM value of -$1.3 million through Dec 2025, up 85.92%, and an annual FY2025 reading of -$1.3 million, up 85.92% over the prior year.
  • Free Cash Flow was $16.8 million for Q4 2025 at Orthofix Medical, up from $2.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $16.8 million in Q4 2025 and bottomed at -$45.5 million in Q1 2023.
  • Average Free Cash Flow over 5 years is -$7.6 million, with a median of -$5.5 million recorded in 2022.
  • The sharpest move saw Free Cash Flow tumbled 577.65% in 2022, then surged 718.85% in 2025.
  • Year by year, Free Cash Flow stood at $5.6 million in 2021, then plummeted by 183.78% to -$4.7 million in 2022, then plummeted by 395.36% to -$23.0 million in 2023, then skyrocketed by 165.94% to $15.2 million in 2024, then grew by 10.67% to $16.8 million in 2025.
  • Business Quant data shows Free Cash Flow for OFIX at $16.8 million in Q4 2025, $2.5 million in Q3 2025, and $4.5 million in Q2 2025.